1. Combivent is a combination of albuterol and ipratropium used to treat COPD and bronchospasm.
2. It works by dilating the bronchial tubes through anticholinergic and beta2-adrenergic mechanisms.
3. Potential adverse effects include CNS effects like dizziness, cardiovascular effects like hypertension, and ENT effects like dry mouth. Nursing considerations include monitoring the patient's respiratory status and educating them and their family on proper use and when to seek medical help.
1. Combivent is a combination of albuterol and ipratropium used to treat COPD and bronchospasm.
2. It works by dilating the bronchial tubes through anticholinergic and beta2-adrenergic mechanisms.
3. Potential adverse effects include CNS effects like dizziness, cardiovascular effects like hypertension, and ENT effects like dry mouth. Nursing considerations include monitoring the patient's respiratory status and educating them and their family on proper use and when to seek medical help.
1. Combivent is a combination of albuterol and ipratropium used to treat COPD and bronchospasm.
2. It works by dilating the bronchial tubes through anticholinergic and beta2-adrenergic mechanisms.
3. Potential adverse effects include CNS effects like dizziness, cardiovascular effects like hypertension, and ENT effects like dry mouth. Nursing considerations include monitoring the patient's respiratory status and educating them and their family on proper use and when to seek medical help.
1. Combivent is a combination of albuterol and ipratropium used to treat COPD and bronchospasm.
2. It works by dilating the bronchial tubes through anticholinergic and beta2-adrenergic mechanisms.
3. Potential adverse effects include CNS effects like dizziness, cardiovascular effects like hypertension, and ENT effects like dry mouth. Nursing considerations include monitoring the patient's respiratory status and educating them and their family on proper use and when to seek medical help.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 2
DRUG STUDY
Date Generic Brand Classification Indication Mechanism of Dosage Adverse Nursing
Name Name Action and Reaction Considerations Frequency Albuterol Combivent Bronchodilato For the Combivent 1 nebule CNS: Assessment and and rs management inhalation solution q20 mins. lightheadedn Drug Effects: ipratropium of is a combination of X 3 doses ess, 1.Monitor inhaler bronchocpas the anticholinergic then q6 drowsiness, respiratory status; m in patients bronchodilator, hours. insomnia, Auscultate lungs suffering ipratropium dizziness, before and after from chronic bromide and beta2- vertigo, CNS inhalation. obstructive adrenergic stimulation 2.Report treatment pulmonary bronchodilator, failure disease salbutamol sulfate, (exacerbation of (COPD) who Ipratropium CV: respiratory requires bromide is a Hypertension, symptoms) to regular quaternary arrhythmia, physician treatment ammonium hypotension, with both derivative of tachycardia, Patient and Family ipratropium atropine and in an angina Education: and anticholinergic drug 1.Do not allow the salbutamol. which has EENT: solution to enter bronchodilator Sinusitis, eyes properties. blurred vision, 2.Consult a doctor Salbutamol dry mouth, immediately in produces paradoxical event of acute, bronchodilation bronchospas rapidly worsening through stimulation m, bronchitis dyspnea. In of beta2-adrenergic addition, the receptors in GIT: patient should be bronchial smooth abdominal warned to seek muscle fibers. This pain, medical advice action is manifested dyspepsia, should a reduced by an increased in gastrointestin response become pulmonary function al distress, apparent. as demonstrated by vomiting, 3.The concomitant spirometric diarrhea, use of Combivent measurements. constipation with other sympathomimetic GUT: dysuria, agents is not urinary recommended since retention, such combined use urinary may lead to difficulty deleterious cardiovascular MS: fatigue effects. 4.Eye pain or discomfort, blurred vision,visual halos or colored images.